Adaptive Biotechnologies Corp
NASDAQ:ADPT
Adaptive Biotechnologies Corp
NASDAQ:ADPT
Price:
4.13 USD
8.68%
Updated:
May 14, 2024
Adaptive Biotechnologies Corp
Other Current Liabilities
|
Adaptive Biotechnologies Corp
Other Current Liabilities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Other Current Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
Other Current Liabilities
$46.9m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Current Liabilities
$2.7B
|
CAGR 3-Years
24%
|
CAGR 5-Years
27%
|
CAGR 10-Years
30%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Current Liabilities
$1.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Current Liabilities
$439.8m
|
CAGR 3-Years
16%
|
CAGR 5-Years
16%
|
CAGR 10-Years
10%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Current Liabilities
$522m
|
CAGR 3-Years
8%
|
CAGR 5-Years
8%
|
CAGR 10-Years
1%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Current Liabilities
$2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
14%
|
CAGR 10-Years
14%
|
See Also
What is Adaptive Biotechnologies Corp's Other Current Liabilities?
Other Current Liabilities
46.9m
USD
46.9m
USD
Based on the financial report for Mar 31, 2024, Adaptive Biotechnologies Corp's Other Current Liabilities amounts to 46.9m USD.
What is Adaptive Biotechnologies Corp's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 5Y
-3%
-3%
Over the last year, the Other Current Liabilities growth was -22%. The average annual Other Current Liabilities growth rates for Adaptive Biotechnologies Corp have been -16% over the past three years , -3% over the past five years .
You don't have any saved screeners yet
